The renal toxicity of cancer chemotherapeutic agents.
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D008727:Methotrexate / Q000009:adverse effects; D008937:Mitomycins / Q000009:adverse effects; D009279:Naphthacenes / Q000009:adverse effects; D009607:Nitrosourea Compounds / Q000009:adverse effects; D008926:Plicamycin / Q000009:adverse effects; D013311:Streptozocin / Q000009:adverse effects; D013866:Thioguanine / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008937:Mitomycins; D009279:Naphthacenes; D009607:Nitrosourea Compounds; D013311:Streptozocin; D003606:Dacarbazine; D003520:Cyclophosphamide; D013866:Thioguanine; D001374:Azacitidine; D008926:Plicamycin; D002945:Cisplatin; D008727:Methotrexate